IP Verse

Oral Pharmaceutical Composition

PatentPatent Analysis

EP2815753

TAIHO PHARMACEUTICAL
Application Number
EP13749171A
Filing Date
Feb 14, 2013
Status
Granted And Under Opposition
Apr 13, 2018
Grant Date
May 16, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP1849470B2
EP3042669B1
EP3012255B1

Bibliography

The patent EP2815753B1 was granted to Taiho Pharmaceutical on May 16, 2018 following the initial filing on Feb 14, 2013 under the application number EP13749171A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

TEVA PHARMACEUTICALSFeb 18, 2019ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents